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Supplementary Fig. 1. Classification and Refinement Scheme for Cryo-EM Data Processing for 
ND6-P25L-CI and the deactive State of WT-CI.  
(A) ND6-P25L-CI. (B) Deactive state of WT-CI. Based on the relative positions of subunit 
NDUFA10 and NDUFA5 the 7.4 Å resolution map from a minor class of ND6-P25L-CI particles 
is also in a deactive-like state, and the 3.7 Å resolution map from a minor class in the deactive 
preparation of WT-CI most likely results from a mixed class of active- and deactive-like particles. 
Related to Figure 1. 
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Supplementary Fig. 2 Resolution Estimates of the Cryo-EM Density Maps for the ND6-P25L-CI 
and the deactive state of WT-CI. 
(A, C) ND6-P25L-CI. (B, D) Deactive state of WT-CI. In (A) and (B), local resolutions were 
estimated using the Local Resolution function in RELION with default parameters and shown 
using UCSF Chimera according to the color bar. In (C) and (D) the estimated global map 
resolutions, defined where the red FSC line = 0.143, are 3.8 and 3.2 Å, respectively. In both cases, 
the refined models agree well with the maps, as shown by the map vs. model FSC curves (blue). 
Related to Figure 1. 
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Supplementary Fig 3. Models and densities for ND6 TMHs 2 and 3 showing the relative positions 
of bulky residues and the mutation site. 
(A) side view from the membrane plane; (B) top view from the matrix side. Densities were rendered 
2 Å from the model in UCFS Chimera at thresholds of 0.0162, 0.0238, and 0.0161 for ND6-P25L, 
deactive and active, respectively. The mesh was surfaced smoothed with two iterations with a factor 
of 0.3. Residues are shown as transparent except for P/L25, F67 and Y69. Related to Figure 1. 
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Supplementary Fig. 4. Structural adjustments associated with rotation of the ND6-TMH3 π bulge.  
The rotation of the ND6-TMH3 π bulge in the ND6-P25L complex I (wheat) (and also in the 
deactive wild-type enzyme, not shown) when it adopts an -helical structure in the active state 
(red) results in an upward motion and reorientation of bulky residues F67 and Y69. There is an 
accompanying shift in the upper portion of ND1-TMH4, resulting in Y127 forming a binding 
pocket (yellow highlight) for the Cys39 on the ND3-TMH1–2 loop, along with NDUFS2-H55. 
This binding site is formed when ordered ND1-TMH5–6, NDUFS2 and ND3-TMH2–3 loops are 
present in the active site. All of these loops are disordered and exposed to the matrix in the ND6-
P25L enzyme and in the deactive state (not shown), resulting in destabilization of the Cys39-
binding pocket (note the partial ND1-TMH5–6 loop of the ND6-P25L enzyme in the destroyed 
binding pocket), straightening of ND1-TMH4 and formation of the ND6–TMH3 π bulge. The 
ubiquinone catalytic ligands (Y108 and H59) and the terminal N2 cluster are shown for reference. 
Colored arrows indicate the general motion observed in transitions to the active state (red) and the 
P25L/deactive states (wheat). Related to Figure 1. 
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Supplementary Fig. 5 Quantification of Mitochondrial H2O2 Production.  
(A, B) The rates of H2O2 production by isolated heart mitochondria at 37 °C in the O2K Oxygraph, 
during respiration on (A) glutamate/malate (0.5 mM) and (B) upon subsequent addition of 
succinate (10 mM). Mitochondria were isolated from four hearts and pooled to provide a single test 
sample. The data are mean averages ± S.E.M. (A, n = 8, B, n = 3, technical replicates) evaluated 
using an unpaired, two-tailed Student’s t-test (**, p < 0.01). In A, p = 0.439 and in B, p = 0.001. 
One of the replicates is shown in Figure 3F. (C, D) The rates of H2O2 production by isolated heart 
mitochondria at room temperature in the Amplex Red plate reader assay, during respiration on (C) 
glutamate/malate (0.5 mM) and (D) upon subsequent addition of succinate (10 mM). Rotenone or 
FCCP (at 5 M) were added as indicated. The data are mean averages ± S.E.M. (n = 3, where each 
replicate is from an independent mitochondrial preparation on a different heart) evaluated using a 
two-way ANOVA test with Tukey’s multiple comparisons correction (****, p < 0.0001). The p 
values in C are: 0.939, 0.875 and 0.999, respectively.  The p values in D are: <0.0001, 0.993 and 
0.999, respectively. Related to Figure 3. 
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Supplementary Table 1  
Cryo-EM Data Collection, Refinement and Validation Statistics. Related to Figure 1. 
 
 
 
 
WT Deactive 
EMD-11810 
PDB 7AK5 
ND6-P25L 
EMD-11811 
PDB 7AK6 
 
Data collection and processing 
  
Magnification  37,600 130,000 
Voltage (kV) 300 300 
Electron exposure (e–/Å2) 50 50 
Defocus range (μm) -2.2 to -3.4 -1.5 to -3.0 
Pixel size (Å) 1.350 1.054 
Symmetry imposed C1 C1 
Initial particle images (no.) 148,440 42,622 
Final particle images (no.) 50,184 26,638 
Map resolution (Å) 
 FSC threshold 
3.18 
0.143 
3.83 
0.143 
Map resolution range (Å) 2.9 to 7.6 3.5 to 8.2 
Map sharpening B factor (Å2) -23 -74 
   
Refinement   
Initial model used  PDB 6ZR2 PDB 6ZR2 
Model resolution (Å) 
 FSC threshold 
3.2 
0.5 
3.9 
0.5 
Model composition 
 Nonhydrogen atoms 
 Protein residues 
 Ligands 
 
65,903 
8,070 
28 
 
65,341 
8,063 
21 
B factors mean (Å2) 
 Protein 
 Ligand 
 
42.79 
38.24 
 
58.21 
57.59 
R.m.s. deviations 
 Bond lengths (Å) 
 Bond angles (°) 
 
0.003 
0.587 
 
0.004 
0.605 
Validation 
 MolProbity score 
 Clashscore, all atoms 
 Poor rotamers (%)  
 
1.80 
7.25 
0.01 
 
2.1 
10.83 
0 
Ramachandran plot 
 Favored (%) 
 Allowed (%) 
 Disallowed (%) 
 
94.05 
5.94 
0.01 
 
89.91 
10.07 
0.01 
EMRinger 2.66 2.19 
   
 
 
  
 
8 
Supplementary Table 2  
Summary of the models for the subunits of deactive and ND6 mouse complex I. Where the values 
differ they are given first for the deactive model, then in brackets for the ND6 model. Related to 
Figure 1. 
 
Subunit Chain 
Total 
residues 
Modeled residues 
% 
Modeled 
Qscore Notes 
       
NDUFV1 F 444 10-437 96.4 0.63 (0.54) FMN, 4Fe4S 
NDUFV2 E 217 5-216 97.7 0.61 (0.51) 2Fe2S 
NDUFS1 G 704 7-692 (6-693) 97.7 (97.4) 0.65 (0.55) 2Fe2S, 2 x 4Fe4S 
NDUFS2 D 430 1-38, 46-54, 61-430 (1-39, 46-54, 60-430)  97.4 (97.0) 0.69 (0.58) Dimethyl-Arg85 
NDUFS3 C 228 7-213 (8-214) 90.8 (90.8) 0.69 (0.59)  
NDUFS7 B 189 35-189 82.0 0.68 (0.58) 4Fe4S 
NDUFS8 I 178 1-178 100 0.69 (0.59) 
2 x 4Fe4S 
no sidechains 8-14 
ND1 H 318 1-60, 67-206, 214-318 (1-203, 214-318) 96.9 (95.9) 0.66 (0.55) N-formyl 
ND2 N 345 1-344 99.7 0.67 (0.56) N-formyl 
ND3 A 115 1-26, 49-115 (1-25, 51-115)  78.2 (80.9) 0.65 (0.52) N-formyl 
ND4 M 459 1-459 100 0.67 (0.56) N-formyl 
ND4L K 98 1-98 100 0.66 (0.56) N-formyl 
ND5 L 607 1-606 99.8 0.64 (0.53) N-formyl 
ND6 J 172 1-171 99.4 0.62 (0.50) 
N-formyl 
no sidechains 108-112 
NDUFV3 s 69 30-68 56.5 0.62 (0.53)  
NDUFS4 Q 133 9-133 94.0 0.67 (0.57)  
NDUFS5 e 105 1-104 99.0 0.66 (0.55) 2 x Cys-Cys (no Cys-Cys) 
NDUFS6 R 96 1-94 97.9 0.68 (0.57) Zn2+ 
NDUFA1 a 70 1-68 97.2 0.67 (0.55)  
NDUFA2 S 98 14-95 83.7 0.58 (0.48)  
NDUFA3 b 83 2-83 (1-83) 100 (98.8) 0.62 (0.51)  
NDUFA5 V 115 4-115 97.4 0.62 (0.53)  
NDUFA6 W 130 17-130 87.7 0.63 (0.52)  
NDUFA7 r 112 1-73, 90-112 85.7 0.66 (0.55) N-acetyl 
NDUFA8 X 171 1-171 100 0.65 (0.55) (2 x Cys-Cys) 
NDUFA9 P 342 
1-185, 200-249, 280-323, 334-342 (1-185, 
199-249, 279-323, 334-342) 
85.1 (84.2) 0.62 (0.53) NADPH 
NDUFA10 O 320 2-320 (1-320) 100 (99.7) 0.65 (0.54) ATP 
NDUFA11 Y 140 1-140 100 0.63 (0.50) 2 x Cys-Cys (1 x Cys-Cys) 
NDUFA12 q 145 2-144 (1-144) 99.3 (98.6) 0.68 (0.56) N-acetyl 
NDUFA13 Z 143 5-143 97.2 0.65 (0.55)  
NDUFAB1 T 88 11-82 (10-82) 83.0 (81.8) 0.47 (0.37) 4’-phosphopantethine +  
3-hydroxyundecanoate NDUFAB1 U 88 1-88 100 0.59 (0.48) 
NDUFB1 f 56 4-54 (5-54) 89.3 (91.1) 0.61 (0.50)  
NDUFB2 j 72 7-68 (6-68) 87.5 (86.1) 0.60 (0.48)  
NDUFB3 k 103 18-94 (17-94) 75.7 (74.8) 0.58 (0.50)  
NDUFB4 m 128 4-128 97.7 0.63 (0.52)  
NDUFB5 h 143 7-143 95.8 0.67 (0.56)  
NDUFB6 i 127 2-35, 64-124 (1-35, 64-124) 75.6 (74.8) 0.60 (0.49) N-acetyl 
NDUFB7 o 136 2-115 (2-112) 81.6 (83.8) 0.56 (0.47)  
NDUFB8 l 157 2-157 99.4 0.65 (0.54)  
NDUFB9 n 178 1-176 98.9 0.64 (0.52)  
NDUFB10 p 175 4-171 96.0 0.63 (0.52) 2 x Cys-Cys 
NDUFB11 g 122 19-120 (21-121)  82.7 (83.6) 0.64 (0.54)  
NDUFC1 c 49 2-47 93.9 0.61 (0.51)  
NDUFC2 d 120 1-119 99.1 0.66 (0.56)  
       
  
 
